Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary porcine granulosa cells | Swine | genital tract | primary cell | plasmid | Metafectene PRO | publication | S-y Jung, Dissertation, 2020, Mississippi State University | Link | |||||
Mouse fetal ovaries | Mouse | genital tract | primary cell | siRNA | RNA-Interference | Metafectene PRO | publication | R. Rosario et al., FASEB J., 2019, 33(12): 14221-14233, doi: 10.1096/fj.201901247R. | Link | ||||
Mouse (18.5 dpc fetal or neonatal) ovaries | Mouse | genital tract | unknown | miRNA | Metafectene | publication | H. Zhang et al., Reproduction, Jun 2014; 148: 43 - 54 | Link | |||||
Mouse cultured fetal ovaries | Mouse | genital tract | primary cell | siRNA | RNA-Interference | Metafectene | publication | B. Xu et al., PLoS One, 2011, 6(1): e16046, doi: 10.1371/journal.pone.0016046 | Link | ||||
Rat primary granulosa cells isolated from Ovaries | Rat | genital tract | primary cell | plasmid | Metafectene | publication | J.-H. Kim et al., Nature Commun., 2014, 5:2936, DOI: 10.1038/ncomms3936 | Link | |||||
Mouse (18.5 dpc fetal or neonatal) ovaries | Mouse | genital tract | unknown | siRNA | RNA-Interference | Metafectene | publication | H. Zhang et al., Reproduction, Jun 2014; 148: 43 - 54 | Link | ||||
Bovine granulosa cells isolated from follicles (2-8 mm in diameter) of bovine ovaries | Cow | genital tract | primary cell | siRNA | RNA-Interference | Metafectene | publication | M. R. Plewes et al., bioRxiv, 2018, doi.org/10.1101/406256 | Link | ||||
Mouse granulosa cells isolated from ICR mouse ovaries | Mouse | genital tract | primary cell | plasmid | Metafectene | publication | J.-H. Kim et al., J. Reprod. Dev., 2014, 60 (1) :14-20 | Link | |||||
Rat (newborn) ovary cells | Rat | genital tract | unknown | siRNA | RNA-Interference | Metafectene | publication | L. Q. Xu et al., Sheng Li Xue Bao, Oct 2009; 61(5): 424-30 | |||||
Hamster fetal ovary (organ culture) | Hamster | genital tract | organ | siRNA | RNA-Interference | Metafectene | publication | S. K. Roy et al., Methods and Protocols, 825, DOI 10.1007/978-1-61779-436-0_12 | |||||
208pgsl |
Chinese hamster ovary cell line defective in UDP-xylose Synthase (derivat of CHO) | Hamster | genital tract | cell line | adherent | plasmid | Metafectene | publication | H. Bakker et al., J. Biol. Chem., Jan 2009; 284: 2576 - 2583 | Link | |||
208pgsl |
Chinese hamster ovary cell line defective in UDP-xylose Synthase (derivat of CHO) | Hamster | genital tract | cell line | adherent | plasmid | Metafectene | publication | A. Ashikov et al., Glycobiology, Mar 2013; 23: 303 - 309 | Link | |||
22Rv1 |
Human prostate epithelial cancer cell line | ATCC CRL-2505 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Ansems et al., The Prostate, 2012, 72: 1708-1717, DOI 10.1002/pros.22522 | |||
6E4 HeLaT |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | sgRNA | CRISPR | Metafectene | publication | D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3 | |||
6E4 HeLaT |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | CRISPR | Metafectene | publication | D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3 | |||
6E4 HeLaT |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | sgRNA | cotransfection (plasmid/sgRNA) | Metafectene | publication | D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3 | |||
6E4 HeLaT |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/sgRNA) | Metafectene | publication | D. Kim et al., Nat ure Struct ural & Molec ular Biology, 2020, 27: 581–588, doi.org/10.1038/s41594-020-0427-3 | |||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | publication | S. Möltgen et al., Cells, 2020, 9, 1322, doi:10.3390/cells9061322 | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. P. Masamha et al., Cancer Res., Aug 2009; 69: 6565 - 6572 | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | C.F.T. Taute, PhD Thesis, 2013, University of the Western Cape | Link | ||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | publication | C. P. Masamha et al., Cancer Res., Aug 2009; 69: 6565 - 6572 | Link | |||
A-2780cis |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Kullmann, 2016, Rheinische Friedrich-Wilhelms-Universität Bonn | Link | ||
C4-2 |
Human prostate carcinoma cell line (derivative of LNCaP) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | R.C. Peery, Dissertation,, 2020, Indiana University | Link | ||
C4-2 |
Human prostate carcinoma cell line (derivat of LNCaP) | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. S. R. Sastry et al., J. Biol. Chem., Jul 2006; 281: 20891 - 20901 | Link |